Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

716results about How to "Increase stimulation" patented technology

Devices and methods for vagus nerve stimulation

InactiveUS7072720B2Great stimulationReadily regulated and reliableSpinal electrodesHead electrodesCardiologyCardiac asystole
The present invention relates to apparatus and methods for electrically inducing and pharmacologically maintaining cardiac asystole. The present invention combines electrostimulation of the vagus nerve to transiently arrest the heart, and the administration of a pharmaceutical composition that suppresses the tendency of the heart to escape from the induced asystolic state. The present invention provides an apparatus to interrogate the response of a heart to an electric pulse applied to the vagus nerve and to select the optimum location of an electrode and pulse to arrest the heart. The present invention further provides embodiments of catheter and tube electrode devices that incorporate expanding electrodes intended to contact the interior walls of blood vessels or anatomic structures in which the electrode devices are implanted. The present invention also provides cutaneous array electrodes that may be used non-invasively to stimulate the vagus nerve.
Owner:EMORY UNIVERSITY

Short duration pre-pulsing to reduce stimulation-evoked side-effects

A method and neurostimulation system of providing therapy to a patient is provided. At least one electrode is placed in contact with tissue of a patient. A sub-threshold, hyperpolarizing, conditioning pre-pulse (e.g., an anodic pulse) is conveyed from the electrode(s) to render a first region of the tissue (e.g., dorsal root fibers) less excitable to stimulation, and a depolarizing stimulation pulse (e.g., a cathodic pulse) is conveyed from the electrode(s) to stimulate a second different region of the tissue (e.g., dorsal column fibers). The conditioning pre-pulse has a relatively short duration (e.g., less than 200 μs).
Owner:BOSTON SCI NEUROMODULATION CORP

Implantable Stimulation Electrode with a Coating for Increasing Tissue Compatibility

InactiveUS20080234790A1Avoid tissue irritationGood biocompatibilitySurgeryInternal electrodesImplantable Stimulation ElectrodesIrritation
An implantable stimulation electrode for use with an implantable tissue stimulator, especially a pacemaker, a defibrillator, a bone stimulator or a neurostimulator includes a metal base body, optionally one or more intermediate layers disposed on the base body and a coating covering the base body and, optionally, intermediate layers in order to increase tissue compatibility. The coating should prevent tissue irritations after implantation and more particularly increase the stimulus threshold associated therewith, have very high biocompatibility and also has an anti-inflammatory effect. An increase in tissue compatibility is achieved by virtue of the fact that the coating has a polysaccharide layer made of hyaluronic acid and / or hyaluronic acid derivatives.
Owner:BIOTRONIK MESS UND THERAPIEGERAETE GMBH & CO

Directed delivery of agents to neural anatomy

InactiveUS20120310140A1Effective pain managementAdequate pain reliefSpinal electrodesPharmaceutical delivery mechanismDiseaseAutomatic control
The present invention is directed generally to systems, devices and methods for direct delivery of agents, e.g., pharmaceutical agents, to target spinal and neuronal anatomies, e.g., the dorsal root ganglia (DRG), for the treatment of various disorders, particularly pain and pain related disorders, such as chronic itch, sensory disorders, multiple sclerosis, post-herpetic neuralgia and the like. The system, devices and methods of the invention encompass the agents to be delivered to the target anatomy alone or in combination with electrical stimulation. The delivery device and systems and methods as disclosed herein place the distal end of the delivery element, which comprises at least one agent delivery structure, and optionally at least one electrode, in close proximity, or in contact with or next to the target spinal anatomy, e.g., DRG. A variety of agents can be delivered using the device, including sodium channel blockers, biologics, neuroinflammatory modulators, toxins etc., to selectively neuromodulate the neurons. Agent delivery and / or electrical stimulation can be automated and / or can be controlled automatically or by a pre-determined program, or by a patient control pump (PCA).
Owner:ST JUDE MEDICAL LUXEMBOURG HLDG SMI S A R L SJM LUX SMI

Multi-axis Adjustable Exercise Machine

A multi-axis adjustable exercise machine which is pivotable about both a pitch axis and a roll axis with respect to a base for allowing an exerciser to perform a wide range of exercises on a pitched or rolled exercise machine. The multi-axis adjustable exercise machine generally includes an exercise machine which is adjustable with respect to a base. The exercise machine may be pivoted about a roll axis to adjust the roll angle of the exercise machine or may be pivoted about a pitch axis to adjust the pitch angle of the exercise machine. One or more actuators may be connected between the base and the exercise machine to effectuate the pivoting of the exercise machine about either or both axes with respect to the base.
Owner:LAGREE TECH INC

System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities

A system and method for providing pulsed electrical stimulation to one or both vagus nerve(s) of a patient to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders. The electrical pulses can be provided either unilaterally or bilaterally (left and right vagus nerves) and can be supra-diaphramatic or be sub-diaphramatic. The system comprising implantable stimulator, lead(s), an external stimulator, and a programmer. The implantable stimulator, comprising a pulse generator module, and a stimulus-receiver module which is used in conjunction with an external stimulator. Control circuitry ensures selective operation of one of the modules of the implanted stimulator, at a time. Further, the external stimulator comprises a telemetry module for remotely activating (or de-activating) programs over the internet, to arrive at the optimal program for each patient. Once the optimal “dose” is titrated using the external stimulator, the implanted pulse generator can then be programmed to similar parameters. The external stimulator in conjunction with the implanted stimulus-receiver can override the implanted pulse generator module, to provide extra dose of therapy, and also to conserve the implanted battery. The external stimulator is networked to other computers. Using the networking, a physician situated remotely can monitor and program the devices, as well as, automatically generate invoicing. In one embodiment, the external stimulator also comprises GPS circuitry for locating patient.
Owner:NEURO & CARDIAC TECH

Posture improvement devices and methods for use

A posture improvement device provides neuromuscular stimulation or proprioceptive therapy using a combination of pressure, torque and angle simultaneously applied to a user in order to train body muscles for proper posture through muscle memory. The device comprises a garment designed to be worn by the user, which is preferably configured like a short-sleeved undershirt or T-shirt. The garment may be fabricated of a stretchable, yet taut material in order to provide the desirable form-fitting feature such that pressure may be readily applied to the surface of the skin for neuromuscular stimulation. This elastomeric material is also preferably breathable and / or which has moisture wicking capabilities.
Owner:ALIGNMED +1

Method and device for transcranial magnetic stimulation

The invention relates to a method for stimulating specific areas of a brain using an induction device, comprising the following steps: recording the spatial structure of the head, in particular the brain; generating a simulation model of the induction device; and arranging the induction device relative to the head such that a specific area of the brain determined by means of the simulation model of the induction device is stimulated by a current flowing in the induction device, as well as to a method for stimulating specific areas of a brain using an induction device, comprising the following steps: recording the spatial structure of the head, in particular the brain; generating a simulation model of the head; and arranging the induction device relative to the head such that a specific area of the brain determined by means of the simulation model of the head is stimulated by a current flowing in the induction device, as well as to a device for stimulating specific areas of a brain using an induction device connected to a marker.
Owner:BRAINLAB

Augmentation of muscle contractility by biphasic stimulation

Augmentation of electrical conduction and contractility by biphasic stimulation of muscle tissue. A first stimulation phase has a first phase polarity, amplitude, and duration. The first stimulation phase, which acts as a conditioning mechanism, is administered at no more than a maximum subthreshold amplitude. A second stimulation phase has a second polarity, amplitude, and duration. The two phases are applied sequentially. Contrary to current thought, anodal stimulation is applied as the first stimulation phase, followed by cathodal stimulation as the second stimulation phase. In this fashion, pulse conduction through muscle is improved, together with an increase in contractibility. Furthermore, this mode of biphasic stimulation reduces the electrical energy required to elicit contraction. In addition, the conditioning first stimulation phase decreases the stimulation threshold by reducing the amount of electrical current required for the second stimulation phase to elicit contraction. The muscle tissue encompassed by the present invention includes skeletal (striated) muscle, cardiac muscle, and smooth muscle.
Owner:MR3 MEDICAL LLC

Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy

The present invention relates to a composition for expanding lymphocytes comprising at least two types of cytokines selected from interleukin 2 (IL-2), interleukin 15 (IL-15) and interleukin 21 (IL-21). It further relates to a Method of preparing a population of clinically relevant lymphocytes, comprising the steps of: obtaining a body sample from a mammal in particular a tissue sample or body liquid sample, comprising at least one lymphocyte and optionally separating the cells in the body sample, culturing the body sample in-vitro to expand and / or stimulate lymphocytes in the sample wherein the culturing comprises using IL-2, IL-15 and / or IL-21, and optionally determining the presence of clinically relevant lymphocyte in the cultured sample. The present invention also relates to an immunotherapy and the population of clinically relevant lymphocytes.
Owner:POLYBIOCEPT GMBH

Phototreatment device for use with coolants and topical substances

Methods and systems are disclosed for phototreatment in which replaceable containers comprising one or more adjuvant (consumable or re-useable) substances are employed. The adjuvant substance can be, for example, a topical substance or a coolant. Systems are disclosed for using a topical substance to detect contact of a phototreatment device with a tissue, detect speed of a phototreatment device over the tissue, detect regions of tissue that have been treated by a phototreatment device and / or to provide other benefits to the tissue such as improved skin tone and texture, tanning, etc. Safety systems are also disclosed that ensure that a proper consumable substance and / or container is connected to a phototreatment device and / or directed to a proper target. Additionally, cooling systems and methods that utilize phase change materials for extracting heat from a light generating device are disclosed.
Owner:PALOMAR MEDICAL TECH

Method of treating an oil or gas well with biodegradable low toxicity fluid system

InactiveUS7231976B2Well remediationIncrease stimulationCleaning apparatusFluid removalMETHYL SOYATEFluid system
A method of treating a well consists of introducing into the wellbore a biodegradable fluid system containing a blend of lactic acid ester, such as ethyl lactate, and a fatty acid ester, such as methyl soyate. The fluid system may be further in the form of a microemulsion that is formed by combining a blend with one or more emulsifiers, an alcohol, and water. The fluid system may be used in displacement, well remediation and stimulation as well as additional, alternative applications such as the cleaning of surface and / or downhole equipment.
Owner:BAKER HUGHES HLDG LLC

Nicotine containing stimulant unit

A saliva-soluble stimulant unit comprising an active ingredient and optional ingredients comprising flavor and aroma additives incorporated in a gel prepared by gelling a water-binding gelling agent, in which the active ingredient comprises nicotine or other alkaloids with the same direction of activity, said unit having i) a texture profile, determined by texture profile analysis, with parameter values of firmness, hardness, brittleness, adhesiveness, elasticity, and cohesiveness within given ranges; (ii) a disintegration time within the range 5-60 minutes; and (iii) a nicotine content from 0.5 to 10 mg or a corresponding content of said alkaloids.
Owner:DAM ANDERS

Cavernous nerve stimulation via unidirectional propagation of action potentials

Methods of using unidirectionally propagating action potentials (UPAPs) for cavernous nerve stimulation and for certain disorders are provided. Stimulators capable of creating such UPAPs include, but are not limited to, miniature implantable stimulators (i.e., microstimulators), possibly with programmably configurable electrodes.
Owner:BOSTON SCI NEUROMODULATION CORP

Method of treating an oil or gas well with biodegradable low toxicity fluid system

InactiveUS7392844B2Well remediationIncrease stimulationConstructionsCleaning apparatusMETHYL SOYATEFluid system
A method of treating a well consists of introducing into the wellbore a biodegradable fluid system containing a fatty acid ester, such as methyl soyate. The fluid system may further contain a lactic acid ester, such as ethyl lactate, and / or a nonionic surfactant. The fluid system may be used in displacement, well remediation and stimulation as well as additional, alternative applications such as the cleaning of surface and / or downhole equipment.
Owner:BAKER HUGHES INC

Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins

The present invention relates to methods and compositions for the prevention and treatment of cancer, inflammatory diseases and disorders or deficiencies of the immune system. The methods of the invention comprise administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand.
Owner:SEAGEN INC

Apparatus and method for ultrasonically and electromagnetically treating tissue

The invention relates to apparatus and method for ultrasonically and electromagnetically treating tissue to treat, for example, traumatized tissue or a bone injury. The apparatus includes at least one ultrasonic transducer assembly and at least one electromagnetic coil-assembly configured to cooperate with a placement module for placement in proximity to the treatment area. The apparatus also utilizes a portable main operating unit constructed to fit within a pouch or carrying case worn by the patient. In operation, at least one ultrasonic transducer and at least one electromagnetic coil are activated by transmitting control signals to the placement module from the main operating unit. The activation of the at least one ultrasonic transducer causes ultrasonic waves to be propagated toward the treatment area which are modulated by electrostatic and magnetic forces generated by the at least one electromagnetic coil. The activation of the at least one ultrasonic transducer and the at least one electromagnetic coil may be performed at the same time or at different times for varying periods.
Owner:EXOGEN

Method of treating an oil or gas well with biodegradable low toxicity fluid system

InactiveUS20060096757A1Increase stimulationWell remediationCleaning apparatusFluid removalMETHYL SOYATEAlcohol
A method of treating a well consists of introducing into the wellbore a biodegradable fluid system containing a blend of lactic acid ester, such as ethyl lactate, and a fatty acid ester, such as methyl soyate. The fluid system may be further in the form of a microemulsion that is formed by combining a blend with one or more emulsifiers, an alcohol, and water. The fluid system may be used in displacement, well remediation and stimulation as well as additional, alternative applications such as the cleaning of surface and / or downhole equipment.
Owner:BAKER HUGHES INC

Electrode vest for electrical stimulation of the abdomen and back

A vest for providing electrical stimulation is disclosed. The vest includes front and rear sections and a controller. Left front and right front electrodes are provided on interior surfaces of the front section, and left rear and right rear electrodes are provided on interior surfaces of the rear section. The controller is provided on an exterior surface of the front section and provides selectively adjustable electrical pulse signals to the electrodes via wires routed over the exterior surface of the front and rear sections to the electrodes through respective openings provided in the front and rear sections. The electrodes and the front and rear sections include means for positional adjustment of the electrodes on the interior surfaces of the front and rear sections. The vest can be used for electrical stimulation of muscles or nerves of the abdomen and back for users having varying body types and sizes.
Owner:TRENT CECILIO

Sexual stimulation device using light therapy

A sexual stimulation apparatus which may comprise a plurality of light sources for photostimulation and microbe reduction of the vagina, clitoris, or both; a plurality of vibrators for mechanical stimulation of the vagina, clitoris, or both; a plurality of modes of operation for achieving improved sexual stimulation in a user; a handle for ease of operation; a controller and programmable memory for containing modes of operation and driving the light sources and vibrators of the invention; a vaginal finger; a clitoral finger; a handle for ease of use; a keypad for user entry of commands; a charging and programming port; and a power source which may be a rechargeable battery which may be rechargeable by direct, inductive or other means; and a handle for ease of operation. The invention also comprises a flexible covering that provides smooth sliding engagement with the vagina and clitoris of a user.
Owner:ZIPPER RALPH

Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema

ActiveUS20100057149A1Prevent disuse atrophyPreserve muscle strengthMassage combsElectrotherapyTissue edemaMuscle tissue
The invention provides systems and methods for neuromuscular electrical stimulation to muscle tissue. Stimulation electrodes may be provided on a stimulation pad, configured to provide electrical stimulation to a target tissue. A system for neuromuscular electrical stimulation may also include pressure generating mechanisms that may provide a compressive force to a region with the target tissue, thereby removing some excess third space fluid from the region.
Owner:SAGE PRODS

Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema

ActiveUS8265763B2Increase stimulationReliably successful transcutaneous stimulationMassage combsElectrotherapyTissue edemaMuscle tissue
The invention provides systems and methods for neuromuscular electrical stimulation to muscle tissue. Stimulation electrodes may be provided on a stimulation pad, configured to provide electrical stimulation to a target tissue. A system for neuromuscular electrical stimulation may also include pressure generating mechanisms that may provide a compressive force to a region with the target tissue, thereby removing some excess third space fluid from the region.
Owner:SAGE PRODS

Animal chew toy containing solid food

An animal toy containing food having a first portion with food delivery means integrated therein adapted to securely house solid food treats, including a nutritional pet supplement, to be removed by the animal during play or through chewing action, and a second side with a plurality of gum stimulation teeth integrated within and projecting therefrom that act to massage the gums of the animal. Food delivery means may be provided as a plurality of cavities integrated within the first portion (and optionally, the second portion), preferably having a grooved or threaded interior for securely holding food pieces securely therein. Alternatively, the food delivery means is provided as a food portion composing the first portion. A pet supplement may be utilized, including joint preserving and joint rebuilding compositions comprising chicken collagen type II, glucosamine hydrochloride and chondroitin sulfate, a vitamin composition comprising vitamins C, D and K, a mineral composition comprising calcium, magnesium, zinc, copper, manganese and boron, a herbal anti-oxidant cofactor blend comprising citrus bioflavonoids, red grapes anthocyanins, turmeric rhizome, boswellia resin and fennel seed.
Owner:I DID IT

Evaluation of reservoir and hydraulic fracture properties in multilayer commingled reservoirs using commingled reservoir production data and production logging information

A method for providing production optimization of reservoir completions having a plurality of completed intervals via available production analysis and production logging data provides a quantitative analysis procedure for reservoir and fracture properties of a commingled reservoir system, that includes the steps of measuring pressure for specific zones in a reservoir; selecting a pressure traverse model; computing midzone pressures using the traverse model; comparing the computed midzone pressures with the measured pressures; and modeling the bottomhole pressure of the reservoir based on the traverse model.
Owner:SCHLUMBERGER TECH CORP

Device and Method for Non-Invasive, Localized Neural Stimulation Utilizing Hall Effect Phenomenon

One aspect of the invention provides a method of stimulating a nerve in tissue of a patient. The method includes the following steps: applying a focused ultrasound beam to the tissue; applying a first magnetic field to the tissue; and applying a second magnetic field to the tissue, the ultrasound beam and the first and second magnetic fields combining to stimulate the nerve. Another aspect of the invention provides a nerve stimulation device having two magnetic coils of opposite polarity each adapted to generate a magnetic field in a patient's tissue, the coils being positioned to generate a substantially toroidal magnetic field within the patient's tissue; and an ultrasound source adapted to transmit a focused ultrasound beam into the patient's tissue.
Owner:KISHAWI EYAD +1

Composition for an in vitro fertilization medium

PCT No. PCT / JP96 / 02503 Sec. 371 Date Mar. 2, 1998 Sec. 102(e) Date Mar. 2, 1998 PCT Filed Sep. 4, 1996 PCT Pub. No. WO97 / 08946 PCT Pub. Date Mar. 13, 1997The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
Owner:FUSO PHARMA INDS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products